-The Hindu Vaccination is important to prevent a second wave Several people have questioned the emergency approval given to the indigenously developed COVID-19 vaccine. They have demanded Efficacy data and cast aspersions on the regulatory machinery. Such views will only increase vaccine hesitancy. It is not the case that the vaccine developed indigenously is being pushed by vested interests, while the international vaccines are great. Questions have been raised about the Moderna and...

-The Hindu They advise against Covaxin, say there is no proof of Efficacy. Several experts have raised concern over the “hasty approval” granted to the COVID-19 vaccines despite the lack of adequate Efficacy data. The Central Drugs Standard Control Organisation on Sunday accorded approval for restricted emergency use of the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute of India (SII), and the indigenously developed vaccine Covaxin of Bharat Biotech. “I’m completely unaware...

-The Telegraph The inadequate sanctioning of schemes across gram panchayats hinders operations, thereby reducing employment opportunities The Mahatma Gandhi National Rural Employment Guarantee Act tracker released by the People’s Action for Employment Guarantee as well as a research report presented by LibTech India reveal why the rural job programme has not been able to cater to the needs of the poorest during this steep rural job crisis. Earlier, a survey by the Azim...

-The Hindu Business Line The food articles’ high weight and their price volatility have reduced the Efficacy of the central bank’s policy actions The flexible inflation targeting framework adopted by RBI in 2016 is considered a significant economic reform in India post 2000. Under this framework, maintaining a 4 per cent CPI headline inflation gets the highest priority in the hierarchy of monetary policy objectives. This rule based policy making renders monetary...

-Livemint.com India has adopted a cautious approach in granting approval to covid-19 vaccines as fast tracking, safety and Efficacy remain primary concern NEW DELHI: Safety and Efficacy are the primary concerns of the government while granting emergency use authorization (EUA) to any covid-19 vaccine in the country. The government's cautious approach before approving a vaccine is apparent. The meeting of the subject expert committee of Central Drugs Standards Control Organisation on Wednesday asked...